Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice

Vaccine

Volumn 32, Issue 46, 2014, Pages 6054-6060

  Chen, Jiansen ^a   Li, Neng ^a   She, Feifei ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Bacterial ghost; DNA vaccine; Helicobacter pylori; Outer inflammatory protein

Indexed keywords

BACTERIAL PROTEIN; DNA VACCINE; GAMMA INTERFERON; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; OUTER INFLAMMATORY PROTEIN; SL7207 BG; UNCLASSIFIED DRUG; BACTERIAL VACCINE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; OIPA PROTEIN, HELICOBACTER PYLORI; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL LOAD; CELL MEMBRANE; CELLULAR IMMUNITY; CODON; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE DELIVERY SYSTEM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMORAL IMMUNITY; IMMUNOPROPHYLAXIS; INFECTION CONTROL; MOUSE; NONHUMAN; SALMONELLA TYPHIMURIUM; SYSTEMATIC REVIEW; TH1 TH2 BALANCE; VACCINATION; ANIMAL; BLOOD; C57BL MOUSE; HELICOBACTER INFECTIONS; IMMUNOLOGY; MICROBIOLOGY; PLASMID; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; STOMACH; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; MICE, INBRED C57BL; PLASMIDS; SALMONELLA TYPHIMURIUM; STOMACH; TH1 CELLS; TH2 CELLS; VACCINES, DNA;

EID: 84907998150     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.09.014     Document Type: Article

References (37)

1. Suzuki H., Saito Y., Hibi T. Helicobacter pylori and gastric mucosa-associated lymphoid tissue (MALT) lymphoma: updated review of clinical outcomes and the molecular pathogenesis. Gut Liver 2009, 3:81-87.
2. Schutze K., Hentschel E., Dragosics B., Hirschl A.M. Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses. Gut 1995, 36:831-833.
3. Muller A., Solnick J.V. Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter 2011, 16(Suppl. 1):26-32.
4. Chen J., Lin L., Li N., She F. Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids. Microbiol Immunol 2012, 56:85-92.
5. Hatzifoti C., Roussel Y., Harris A.G., Wren B.W., Morrow J.W., Bajaj-Elliott M. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori. Helicobacter 2006, 11:113-122.
6. Mohit E., Rafati S. Biological delivery approaches for gene therapy: strategies to potentiate efficacy and enhance specificity. Mol Immunol 2013, 56:599-611.
7. Mazid R., Tan M.X., Danquah M.K. Molecular delivery of plasmids for genetic vaccination. Curr Pharm Biotechnol 2013, 14:615-622.
8. Langemann T., Koller V.J., Muhammad A., Kudela P., Mayr U.B., Lubitz W. The bacterial ghost platform system: production and applications. Bioeng Bugs 2010, 1:326-336.
9. Lubitz W. Bacterial ghosts as carrier and targeting systems. Expert Opin Biol Ther 2001, 1:765-771.
10. Muhammad A., Champeimont J., Mayr U.B., Lubitz W., Kudela P. Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications. Expert Rev Vaccines 2012, 11:97-116.
11. Paukner S., Stiedl T., Kudela P., Bizik J., Al Laham F., Lubitz W. Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery. Expert Opin Drug Deliv 2006, 3:11-22.
12. Mader H.J., Szostak M.P., Hensel A., Lubitz W., Haslberger A.G. Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines. Vaccine 1997, 15:195-202.
13. Kudela P., Paukner S., Mayr U.B., Cholujova D., Kohl G., Schwarczova Z., et al. Effective gene transfer to melanoma cells using bacterial ghosts. Cancer Lett 2008, 262:54-63.
14. Vilte D.A., Larzábal M., Mayr U.B., Garbaccio S., Gammella M., Rabinovitz B.C., et al. A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts (BGs) reduces the excretion of E. coli O157:H7 in calves. Vet Immunol Immunopathol 2012, 146:169-176.
15. Jawale C.V., Chaudhari A.A., Jeon B.W., Nandre R.M., Lee J.H. Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/lambda PR/gene E expression system. Infect Immun 2012, 80:1502-1509.
16. Wen J., Yang Y., Zhao G., Tong S., Yu H., Jin X., et al. Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway. Vaccine 2012, 30:5733-5739.
17. Wang X., Lu C. Mice orally vaccinated with Edwardsiella tarda ghosts are significantly protected against infection. Vaccine 2009, 27:1571-1578.
18. Marchart J., Rehagen M., Dropmann G., Szostak M.P., Alldinger S., Lechleitner S., et al. Protective immunity against pasteurellosis in cattle, induced by Pasteurella haemolytica ghosts. Vaccine 2003, 21:1415-1422.
19. Marchart J., Dropmann G., Lechleitner S., Schlapp T., Wanner G., Szostak M.P., et al. Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates. Vaccine 2003, 21:3988-3997.
20. Haslberger A.G., Kohl G., Felnerova D., Mayr U.B., Fürst-Ladani S., Lubitz W. Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells. J Biotechnol 2000, 83:57-66.
21. Ekong E.E., Okenu D.N., Mania-Pramanik J., He Q., Igietseme J.U., Ananaba G.A., et al. A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin. FEMS Immunol Med Microbiol 2009, 55:280-291.
22. Cai K., Zhang Y., Yang B., Chen S. Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice. Vaccine 2013, 31:334-340.
23. Panthel K., Jechlinger W., Matis A., Rohde M., Szostak M., Lubitz W., et al. Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates. Infect Immun 2003, 71:109-116.
24. Talebkhan Y., Bababeik M., Esmaeili M., Oghalaei A., Saberi S., Karimi Z., et al. Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine. J Microbiol Methods 2010, 82:334-337.
25. Chen J., Lin M., Li N., Lin L., She F. Therapeutic vaccination with Salmonella-delivered codon-optimized outer inflammatory protein DNA vaccine enhances protection in Helicobacter pylori infected mice. Vaccine 2012, 30:5310-5315.
26. Paukner S., Kudela P., Kohl G., Schlapp T., Friedrichs S., Lubitz W. DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Mol Ther 2005, 11:215-223.
27. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 2007, 12:89-102.
28. Hoffelner H., Haas R. Recombinant bacterial ghosts: versatile targeting vehicles and promising vaccine candidates. Int J Med Microbiol 2004, 294:303-311.
29. Paukner S., Kohl G., Lubitz W. Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells. J Control Release 2004, 94:63-74.
30. Ebensen T., Paukner S., Link C., Kudela P., de Domenico C., Lubitz W., et al. Bacterial ghosts are an efficient delivery system for DNA vaccines. J Immunol 2004, 172:6858-6865.
31. Wang X., Lord D.M., Cheng H.Y., Osbourne D.O., Hong S.H., Sanchez-Torres V., et al. A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat Chem Biol 2012, 8:855-861.
32. Cai K., Gao X., Li T., Hou X., Wang Q., Liu H., et al. Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response. Can J Microbiol 2010, 56:389-398.
33. Eko F.O., Okenu D.N., Singh U.P., He Q., Black C., Igietseme J.U. Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate. Vaccine 2011, 29:3802-3810.
34. Haidinger W., Mayr U.B., Szostak M.P., Resch S., Lubitz W. Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nuclease. Appl Environ Microbiol 2003, 69:6106-6113.
35. Walcher P., Cui X., Arrow J.A., Scobie S., Molinia F.C., Cowan P.E., et al. Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula). Vaccine 2008, 26:6832-6838.
36. Mayrhofer P., Tabrizi C.A., Walcher P., Haidinger W., Jechlinger W., Lubitz W. Immobilization of plasmid DNA in bacterial ghosts. J Control Release 2005, 102:725-735.
37. Tuntufye H.N., Ons E., Pham A.D.N., Luyten T., Van Gerven N., Bleyen N., et al. Escherichia coli ghosts or live E. coli expressing the ferri-siderophore receptors FepA, FhuE, IroN and IutA do not protect broiler chickens against avian pathogenic E. coli (APEC). Vet Microbiol 2012, 159:470-478.